TW200635575A - Use of substituted cyclopropane acid derivatives for producing medicaments for treating the metabolic syndrome - Google Patents

Use of substituted cyclopropane acid derivatives for producing medicaments for treating the metabolic syndrome

Info

Publication number: TW200635575A
Authority: TW; Taiwan
Prior art keywords: metabolic syndrome; acid derivatives; treating; producing medicaments; substituted cyclopropane
Prior art date: 2004-12-14

Application number

TW094143771A

Other languages

English (en)

Inventor

Dieter Kadereit

Siegfried Stengelin

Hubert Heuer

Harm Brummerhop

Original Assignee

Sanofi Aventis Deutschland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-14

Filing date

2005-12-12

Publication date

2006-10-16

2004-12-14 Priority claimed from DE102004060041A external-priority patent/DE102004060041A1/de

2005-12-12 Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland

2006-10-16 Publication of TW200635575A publication Critical patent/TW200635575A/zh

Links

208000001145 Metabolic Syndrome Diseases 0.000 title abstract 3
201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 title abstract 3
239000003814 drug Substances 0.000 title abstract 3
239000002253 acid Substances 0.000 title abstract 2
125000001559 cyclopropyl group Chemical class [H]C1([H])C([H])([H])C1([H])* 0.000 title abstract 2
150000003839 salts Chemical class 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Psychiatry (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pulmonology (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

TW094143771A 2004-12-14 2005-12-12 Use of substituted cyclopropane acid derivatives for producing medicaments for treating the metabolic syndrome TW200635575A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102004060041A DE102004060041A1 (de)	2004-12-14	2004-12-14	Verwendung von substituierten Cyclopropansäurederivaten zur Herstellung von Medikamenten zur Behandlung des Metabolischen Syndroms
DE102005039245		2005-08-19

Publications (1)

Publication Number	Publication Date
TW200635575A true TW200635575A (en)	2006-10-16

Family

ID=35945136

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW094143771A TW200635575A (en)	2004-12-14	2005-12-12	Use of substituted cyclopropane acid derivatives for producing medicaments for treating the metabolic syndrome

Country Status (20)

Country	Link
US (2)	US20080045590A1 (zh)
EP (1)	EP1827415B1 (zh)
JP (1)	JP2008523122A (zh)
KR (1)	KR20070086194A (zh)
AR (1)	AR052265A1 (zh)
AT (1)	ATE455543T1 (zh)
AU (1)	AU2005315975A1 (zh)
BR (1)	BRPI0519064A2 (zh)
CA (1)	CA2590024A1 (zh)
DE (1)	DE502005008929D1 (zh)
IL (1)	IL183464A0 (zh)
MA (1)	MA29131B1 (zh)
MX (1)	MX2007006798A (zh)
MY (1)	MY138165A (zh)
NO (1)	NO20073031L (zh)
NZ (1)	NZ555155A (zh)
RU (1)	RU2007126842A (zh)
TW (1)	TW200635575A (zh)
UY (1)	UY29256A1 (zh)
WO (1)	WO2006063681A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8053867B2 (en) *	2008-08-20	2011-11-08	Honeywell International Inc.	Phosphorous-comprising dopants and methods for forming phosphorous-doped regions in semiconductor substrates using phosphorous-comprising dopants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL157412A0 (en) *	2001-02-16	2004-03-28	Aventis Pharmaceuticals Inc Av	Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
PE20030701A1 (es) *	2001-12-20	2003-08-21	Schering Corp	Compuestos para el tratamiento de trastornos inflamatorios
CA2470591A1 (en) *	2001-12-20	2003-07-03	Merck & Co., Inc.	Therapeutic compounds for treating dyslipidemic conditions

2005
- 2005-11-30 MX MX2007006798A patent/MX2007006798A/es not_active Application Discontinuation
- 2005-11-30 JP JP2007545874A patent/JP2008523122A/ja not_active Abandoned
- 2005-11-30 RU RU2007126842/15A patent/RU2007126842A/ru not_active Application Discontinuation
- 2005-11-30 AT AT05814551T patent/ATE455543T1/de not_active IP Right Cessation
- 2005-11-30 WO PCT/EP2005/012763 patent/WO2006063681A1/de not_active Ceased
- 2005-11-30 EP EP05814551A patent/EP1827415B1/de not_active Expired - Lifetime
- 2005-11-30 KR KR1020077013437A patent/KR20070086194A/ko not_active Withdrawn
- 2005-11-30 BR BRPI0519064-9A patent/BRPI0519064A2/pt not_active IP Right Cessation
- 2005-11-30 CA CA002590024A patent/CA2590024A1/en not_active Abandoned
- 2005-11-30 AU AU2005315975A patent/AU2005315975A1/en not_active Abandoned
- 2005-11-30 NZ NZ555155A patent/NZ555155A/en not_active IP Right Cessation
- 2005-11-30 DE DE502005008929T patent/DE502005008929D1/de not_active Expired - Lifetime
- 2005-12-12 TW TW094143771A patent/TW200635575A/zh unknown
- 2005-12-12 AR ARP050105191A patent/AR052265A1/es not_active Application Discontinuation
- 2005-12-13 MY MYPI20055838A patent/MY138165A/en unknown
- 2005-12-20 UY UY29256A patent/UY29256A1/es unknown
2007
- 2007-05-28 IL IL183464A patent/IL183464A0/en unknown
- 2007-06-07 US US11/759,510 patent/US20080045590A1/en not_active Abandoned
- 2007-06-12 MA MA29989A patent/MA29131B1/fr unknown
- 2007-06-14 NO NO20073031A patent/NO20073031L/no not_active Application Discontinuation
2008
- 2008-12-04 US US12/328,052 patent/US8222240B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NO20073031L (no)	2007-08-03
US8222240B2 (en)	2012-07-17
AR052265A1 (es)	2007-03-07
DE502005008929D1 (de)	2010-03-11
KR20070086194A (ko)	2007-08-27
ATE455543T1 (de)	2010-02-15
MA29131B1 (fr)	2008-01-02
RU2007126842A (ru)	2009-01-27
MY138165A (en)	2009-04-30
MX2007006798A (es)	2007-08-07
IL183464A0 (en)	2007-10-31
CA2590024A1 (en)	2006-06-22
WO2006063681A1 (de)	2006-06-22
BRPI0519064A2 (pt)	2008-12-23
NZ555155A (en)	2009-09-25
AU2005315975A1 (en)	2006-06-22
EP1827415B1 (de)	2010-01-20
UY29256A1 (es)	2006-07-31
US20080045590A1 (en)	2008-02-21
US20090088474A1 (en)	2009-04-02
EP1827415A1 (de)	2007-09-05
JP2008523122A (ja)	2008-07-03

Publication	Publication Date	Title
TN2009000275A1 (en)	2010-10-18	Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
IL173203A0 (en)	2006-06-11	Novel cyano thiazolides, methods for the production thereof, and use thereof as a medicament
MX2009008228A (es)	2009-08-12	N-adamantil benzamidas como inhibidores de la dehidrogenasa 11-beta-hidroxiesteroide.
MX2009006742A (es)	2009-08-24	Inhibidores acilaminopirazoles como fgfr.
MY148108A (en)	2013-02-28	Medicaments for the treatment or prevention of fibrotic diseases
ATE369353T1 (de)	2007-08-15	Medizinisch verwendbare arylethanolamin verbindungen
EA200970611A1 (ru)	2009-12-30	Замещенные пиразолохиназолиновые производные, способ их получения и их применение в качестве ингибиторов киназы
EA201001669A1 (ru)	2011-06-30	Замещенные пиримидин-5-карбоксамиды 281
MX2008016134A (es)	2009-01-15	Derivados de fenol para el tratamiento de enfermedades respiratorias.
EA201200318A1 (ru)	2012-09-28	Гетероциклические оксимы
MY143565A (en)	2011-05-31	Novel fluorocglycoside derivatives of pyrazoles: medicaments containing these compounds, and the use thereof
TW200635899A (en)	2006-10-16	Chemical compounds
WO2005075425A3 (en)	2006-12-14	Substituted bisarylurea derivatives as kinase inhibitors
WO2008101907A3 (en)	2008-10-23	N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
TW200736234A (en)	2007-10-01	Chemical compounds
BRPI0412999A (pt)	2006-10-03	2-aminotetralina substituìda para tratamento de depressão
UA107578C2 (uk)	2015-01-26	Комбінована терапія при лікуванні діабету
TW200604193A (en)	2006-02-01	Substituted oxazole-benzoisothiazole dioxide derivatives, process for their preparation and their use
NO20064186L (no)	2006-11-14	Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod
TW200635878A (en)	2006-10-16	Hydroxybiphenylcarboxylic acids and derivatives, processes for preparing them and their use
UA101393C2 (ru)	2013-03-25	КОМПОЗИЦИИ И ПРИМЕНЕНИЕ ПРОИЗВОДНЫХ ТРИАЗОЛА ДЛЯ ЛЕЧЕНИЯ β-АМИЛОИДОЗОВ И СИНУКЛЕИНОПАТИЙ
EA200971086A1 (ru)	2010-04-30	Фармацевтические композиции и способ лечения шизофрении
EA201490630A1 (ru)	2014-08-29	6-замещенные 3-(хинолин-6-илтио)[1,2,4]триазоло[4,3-a]пиридины в качестве ингибиторов c-met тирозинкиназы
TW200616985A (en)	2006-06-01	Salicylthiazoles substituted by diphenylamine or diphenylamine derivatives, process for their preparation and their use
MXPA05010020A (es)	2005-11-17	Derivados de oxamida.